Merit Medical Systems Inc (MMSI) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally.

Total Assets Chart for Merit Medical Systems Inc

Merit Medical Systems Inc (MMSI) total assets for FY2025 were USD 2.7B, a 11.1% change from FY2024. Merit Medical Systems Inc's total assets grew from USD 1.6M in 1989 to USD 2.7B in 2025 (167770.1% over 36 years). Total assets compound annual growth rate: 5-year CAGR of 10.0%, 10-year CAGR of 13.2%, 20-year CAGR of 15.1%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$5.57B
Implied Share Price
$93.30
Enterprise Value
$5.58B
Revenue (TTM)
$1.58B
EBITDA
$338.94M
Profit Margin
9.22%
Trailing P/E
38.40
Forward P/E
18.94
Price/Book (MRQ)
3.10
Price/Sales (TTM)
3.53
EV/EBITDA
15.42
EV/Revenue
3.54
Dividend Yield
—
Book Value
$28.13
Free Cash Flow (FY2025)
$212.53M
Free Cash Flow Yield
3.82%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.